Link Copied!
Treatments
On this page
- Please note that as of April 2023, this website is no longer actively being updated.
- COVID-19 Guidelines Dashboard
- Overview by Severity
- Oral Antiviral Outpatient Test-to-Treat Algorithm
- Corticosteroids
- Recommendations
- Dosing
- Antivirals
- Remdesivir
- Nirmatrelvir/ritonavir
- Molnupiravir
- Other Antivirals
- Antibodies
- Monoclonal Antibodies
- Convalescent Plasma
- Immunomodulators
- Anti-IL-6 Agents (e.g. Tocilizumab)
- JAK Inhibitors (e.g. Baricitinib)
- Anti-IL-1 Agents (e.g. Anakinra)
- Symptomatic Treatments
- Cough
- Dyspnea
- Pain
- Anxiety
- Respiratory Secretions
- Nausea and Vomiting
- Delirium
- Anticoagulation
- Prophylactic Dosing
- Therapeutic Dosing
- Aspirin
- Antibiotics
- Choice of Antibiotics
- Treatments for Comorbid Diseases
- RAAS Inhibitors
- Statins
- Calcium Channel Blockers
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Bronchodilators
- Inhaled Corticosteroids
- Blood Products
- Immunosuppressants
- Other Miscellaneous Agents
- Hydroxychloroquine
- Azithromycin
- Ivermectin
- Nitazoxanide
- Famotidine
- Vitamins & Minerals
- Zinc
- Vitamin C
- Clinical Trials
- Baseline Immunosuppression
- COVID-19 Risk by Medication
- Management of Baseline Immunosuppression